Amicus Therapeutics was founded in 2002 to develop innovative therapies for rare, devastating diseases that lack effective treatments. Over the years, the company has invested heavily in research to successfully bring new treatments to market. The company has taken a rare disease focus and has become one of the largest biotech companies in the world.
